Romain-David Seban
ScholarGPS® ID: 47439534445293
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Positron Emission Tomography | PET-CT | Cancer | Medical Imaging | Biomarker | Cancer Immunotherapy
Metrics Summary
Publication Count
55
Predicted Citations
1,158
Predicted h-index
18
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Thyroid®, volume 33, issue 11, pages 1327-1338 (2023). |
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers (journal article) European Journal of Nuclear Medicine and Molecular Imaging, volume 50, issue 13, pages 4010-4023 (2023). |
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab (journal article) European Journal of Nuclear Medicine and Molecular Imaging, volume 50, issue 13, pages 4024-4035 (2023). |
Cancers, volume 15, issue 21, pages 5179- (2023). |
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer (journal article) Journal of Clinical Medicine, volume 12, issue 17, pages 5487- (2023). |
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer (journal article) Journal of Clinical Medicine, volume 12, issue 15, pages 4882- (2023). |
Advances in PET/CT Imaging for Breast Cancer (journal article) Journal of Clinical Medicine, volume 12, issue 13, pages 4537- (2023). |
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients (journal article) Journal of Nuclear Medicine, volume 64, issue 7, pages 1164-1165 (2023). |
Cancers, volume 15, issue 8, pages 2223- (2023). |
68Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor (journal article) Clinical Nuclear Medicine, volume 48, issue 5, pages e228-e229 (2023). |
Advances in PET/CT Imaging for Breast Cancer Patients and Beyond (journal article) Journal of Clinical Medicine, volume 12, issue 2, pages 651- (2023). |
Cancer Imaging, volume 22, issue 1 (2022). |
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging (journal article) Seminars in Cancer Biology, volume 86 (2022). |
Journal of Nuclear Medicine, volume 63, issue 8, pages 1231-1238 (2022). |
European Journal of Nuclear Medicine and Molecular Imaging, volume 49, issue 7, pages 2323-2341 (2022). |
Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer (journal article) Thyroid, volume 32, issue 5, pages 594-598 (2022). |
Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline18 F-FDG PET/CT in Metastatic Melanoma (journal article) Journal of Nuclear Medicine, volume 63, issue 1, pages 166.2-166 (2022). |
Frontiers Media SA (2022) |
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked (journal article) Current Cancer Drug Targets, volume 21, issue 11, pages 944-952 (2021). |
Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology? (journal article) European Journal of Nuclear Medicine and Molecular Imaging, volume 48, issue 11, pages 3351-3352 (2021). |